Skip to main content
. Author manuscript; available in PMC: 2015 Jun 5.
Published in final edited form as: Am J Obstet Gynecol. 2015 Jan 9;212(6):717–724. doi: 10.1016/j.ajog.2015.01.012

TABLE 1.

Early-stage survival of uterine sarcomas

Variable Year published Stage n Survival outcome
Leiomyosarcoma
  Kapp et al3 2008 I 951 5-yr DSS = 75.8%
II 43 5-yr DSS = 60.1%
  Abeler et al4 2009 I 193 5-yr OS = 51%
II 36 5-yr OS = 25%
Endometrial stromal sarcoma
  Chan et al5 2008 I–II 540 6-yr DSS = 89%
  Abeler et al4 2009 I 56 5-yr OS = 84%
II 21 5-yr OS = 62%
Adenosarcoma
  Arend et al6 2010 I 327 5-yr OS = 79%
Undifferentiated uterine sarcoma
  Abeler et al4 2009 I 14 5-yr OS = 57%
II 5 5-yr OS = 0%
  Tanner et al7 2012 I 7 Median OS = 26.8 mo

DSS, disease specific survival; OS, overall survival.

Liu. Critical assessment of morcellation. Am J Obstet Gynecol 2015.